期刊
EUROPEAN JOURNAL OF RADIOLOGY
卷 73, 期 3, 页码 481-493出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ejrad.2009.12.024
关键词
Endocrine tumours; Diagnostic strategies; PET and PET/CT; Radiopharmaceuticals
Functional information provided by PET tracers together with the superior image quality and the better data quantification by PET technology had a changing effect on the significance of nuclear medicine in medical issues. Recently introduced hybrid PET/CT systems together with the introduction of novel PET radiopharmaceuticals have contributed to the fact that nuclear medicine has become a growing diagnostic impact on endocrinology. In this review imaging strategies, different radiopharmaceuticals including the basic mechanism of their cell uptake, and the diagnostic value of PET and PET/CT in endocrine tumours except differentiated thyroid carcinomas will be discussed. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据